This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of cell membranes. It has antibacterial effects on dermatophytes and Candida.

This product is a non-steroidal anti-inflammatory drug. In addition to inhibiting cyclooxygenase, it also has a certain effect of inhibiting lipoxygenase and reducing bradykinin, thereby alleviating the pain sensation at the site of inflammation and injury.

This product is a semi-synthetic clindamycin derivative and a narrow-spectrum antibiotic. This product has strong antibacterial activity against Gram-positive cocci and anaerobic bacteria. In vitro tests show that this product has the effect of inhibiting the growth of Propionibacterium acnes, Propionibacterium granulosum, Staphylococcus aureus, Staphylococcus epidermidis, etc.

Liranabate is a thiocarbamate antifungal drug and a squalene epoxidase inhibitor. It exerts its antifungal effect by inhibiting the epoxidation reaction of squalene in fungal cell membranes and affecting the synthesis of ergosterol, a component of cell membranes. Liranabate has a strong antifungal effect on skin filamentous fungi (Trichophyton, Microsporum, Epidermophyton), and also shows antifungal effects on other filamentous fungi, dark fungi, and dimorphic fungi.

It has anti-inflammatory properties and can relieve the inflammatory white reaction of acne (such as pustules) by normalizing the differentiation of hair cells on hair follicles and reducing the formation of tiny comedones.

Retinoids, which have anti-inflammatory properties, can treat acne and have effects on acne vulgaris and differentiation processes, inhibiting the chemotaxis of human polymorphonuclear leukocytes and the production of inflammatory mediators.